Anthem Biosciences Limited (NSE:ANTHEM)
India · Delayed Price · Currency is INR 690.85
-2.35 (-0.34%)
Feb 18, 2026, 1:30 PM IST
Anthem Biosciences Market Cap
Anthem Biosciences has a market cap or net worth of 389.31 billion as of February 17, 2026.
Market Cap
389.31B
Enterprise Value
380.09B
Revenue
20.02B
Ranking
n/a
PE Ratio
80.83
Stock Price
690.85
Market Cap Chart
Since July 21, 2025, Anthem Biosciences's market cap has decreased from 410.17B to 389.31B, a decrease of -5.09%. That is a compound annual growth rate of -8.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 16, 2026 | 387.45B | 5.89% |
| Dec 31, 2025 | 365.89B | -10.80% |
| Jul 21, 2025 | 410.17B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Biocon | 615.55B |
| OneSource Specialty Pharma | 137.27B |
| Concord Biotech | 121.75B |
| Blue Jet Healthcare | 62.03B |
| Supriya Lifescience | 54.19B |
| Zota Health Care | 46.49B |
| Dishman Carbogen Amcis | 30.82B |
| Panacea Biotec | 21.24B |